Healthcare

Our Healthcare team seeks to partner with leading healthcare providers, pharmaceutical companies, diagnostics businesses, payer services, medical products manufacturers, and healthcare technology companies. With deep sector expertise and a global footprint, we support management teams in building durable, mission-critical businesses that improve patient outcomes, increase efficiency, and expand access to care.

We provide long-term partnership to strengthen operations, scale platforms, and support global expansion. It’s how we help transform local and regional leaders into global product and service providers.

Strategy and approach

Our Healthcare team invests in businesses we view as aligned with the long-term structural trends that shape healthcare delivery globally. We draw on decades of expertise to navigate the complexity of healthcare and the need for patient capital, execution discipline, and deep sector insight. While healthcare systems, regulation, and reimbursement frameworks vary by region, we focus on companies positioned to benefit from shared, secular demand drivers and evolving care models.

Investment themes

We anchor our investment strategy in several core themes influencing the global healthcare industry. Across these themes, we seek businesses that are part of the solution, whether through innovation, quality and experience improvement, cost reduction, or an enhanced patient and consumer experience. These themes include:

• Biotech and medtech innovation. Investing behind innovative therapies and technologies that are expanding pharma and medtech markets and improving speed, accuracy, and precision.
• Technology adoption. Accelerating technology adoption across healthcare to improve transparency, efficiency, and patient outcomes.
• Shifting care settings. Advancing lower-cost, patient-centric care by moving treatment from inpatient settings to home, outpatient, and digital-first models
• Reducing cost and complexity. Enabling providers, payers and pharma to outsource non-core functions and improve efficiency.

Sub-industry focus areas

We invest across healthcare subsectors where innovation, scale, and operational improvement drive durable growth and long-term value creation.

• Life sciences. Backing tools, services, and platforms that enable research, development, and manufacturing across the biopharma value chain.
• Medtech. Supporting differentiated devices and diagnostics that improve clinical outcomes and enable minimally invasive care with global scale.
• Healthcare IT. Scaling software and data platforms that modernize care delivery, improve interoperability, and reduce administrative complexity.
• Pharmacy. Investing in pharmacy platforms that improve access, efficiency, and patient adherence across retail, specialty, and clinical settings.
• Home health. Expanding home-based care models that shift treatment from acute settings while improving patient experience and cost efficiency.
• Pharma commercialization. Building commercialization and services platforms that help biopharma companies launch, scale, and optimize products globally.
• Other healthcare services. Partnering with essential healthcare service providers that deliver mission-critical solutions across the ecosystem.